Spero Therapeutics (SPRO) Earnings Date, Estimates & Call Transcripts

$1.44
+0.03 (+2.14%)
(As of 04/23/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Mar. 13)
$0.96 Beat By $1.14
Consensus EPS
(Mar. 13)
-$0.18
Skip Charts & View Estimated and Actual Earnings Data

SPRO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SPRO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Spero Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.12)($0.12)($0.12)
Q2 20241($0.41)($0.41)($0.41)
Q3 20241($0.16)($0.16)($0.16)
Q4 20241($0.21)($0.21)($0.21)
FY 20244($0.90)($0.90)($0.90)

SPRO Earnings Date and Information

Spero Therapeutics last issued its earnings results on March 13th, 2024. The reported $0.96 EPS for the quarter, beating analysts' consensus estimates of ($0.18) by $1.14. The firm earned $73.52 million during the quarter, compared to the consensus estimate of $19.40 million. Spero Therapeutics has generated $0.42 earnings per share over the last year ($0.42 diluted earnings per share) and currently has a price-to-earnings ratio of 3.4. Earnings for Spero Therapeutics are expected to grow in the coming year, from ($0.94) to ($0.90) per share. Spero Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Spero Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
3/13/2024Q4 2023($0.18)$0.96+$1.14$0.96$19.40 million$73.52 million
11/13/2023Q3 2023($0.15)$0.02+$0.17$0.10$2.40 million$25.47 million    
8/10/2023Q2 2023($0.29)($0.23)+$0.06($0.23)$2.20 million$2.72 million
5/11/2023Q1 2023($0.35)($0.25)+$0.10($0.25)$2.00 million$2.07 million
3/30/2023Q4 2022($0.40)$0.55+$0.95$0.55$1.60 million$47.44 million
11/14/2022Q3 2022($0.34)($0.33)+$0.01($0.33)$6.75 million$2.01 million
8/10/2022Q2 2022($0.88)($0.87)+$0.01($0.87)$2.30 million$1.99 million
5/16/2022Q1 2022($0.87)($1.01)($0.14)($1.01)$2.85 million$2.07 million    
3/31/2022Q4 2021($0.80)($0.90)($0.10)($0.90)$2.90 million$2.74 million    
11/10/2021Q3 2021($0.66)($0.70)($0.04)($0.70)$3.00 million$3.06 million    
8/5/2021Q2 2021($0.77)($0.63)+$0.14($0.63)$2.55 million$5.15 million  
5/6/2021Q1 2021($0.61)($0.66)($0.05)($0.66)$2.71 million$7.30 million  

Spero Therapeutics Earnings - Frequently Asked Questions

When is Spero Therapeutics's earnings date?

Spero Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on SPRO's earnings history.

Did Spero Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Spero Therapeutics (NASDAQ:SPRO) reported $0.96 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.18) by $1.14. Learn more on analysts' earnings estimate vs. SPRO's actual earnings.

How much revenue does Spero Therapeutics generate each year?

Spero Therapeutics (NASDAQ:SPRO) has a recorded annual revenue of $103.78 million.

How much profit does Spero Therapeutics generate each year?

Spero Therapeutics (NASDAQ:SPRO) has a recorded net income of $22.81 million. SPRO has generated $0.42 earnings per share over the last four quarters.

What is Spero Therapeutics's price-to-earnings ratio?

Spero Therapeutics (NASDAQ:SPRO) has a trailing price-to-earnings ratio of 3.42.

What is Spero Therapeutics's EPS forecast for next year?

Spero Therapeutics's earnings are expected to grow from ($0.94) per share to ($0.90) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:SPRO) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners